The Korea Times
amn_close.png
amn_bl.png
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
amn_bl.png
Business
  • Tech
  • Bio
  • Companies
amn_bl.png
Finance
  • Companies
  • Economy
  • Markets
  • Cryptocurrency
amn_bl.png
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to President
  • Letter to the Editor
amn_bl.png
Lifestyle
  • Travel & Food
  • Trends
  • People & Events
  • Books
  • Around Town
  • Fortune Telling
amn_bl.png
Entertainment & Arts
  • K-pop
  • Films
  • Shows & Dramas
  • Music
  • Theater & Others
amn_bl.png
Sports
amn_bl.png
World
  • SCMP
  • Asia
amn_bl.png
Video
  • Korean Storytellers
  • POPKORN
  • Culture
  • People
  • News
amn_bl.png
Photos
  • Photo News
  • Darkroom
amn_NK.png amn_DR.png amn_LK.png amn_LE.png
  • bt_fb_on_2022.svgbt_fb_over_2022.svg
  • bt_twitter_on_2022.svgbt_twitter_over_2022.svg
  • bt_youtube_on_2022.svgbt_youtube_over_2022.svg
  • bt_instagram_on_2022.svgbt_instagram_over_2022.svg
The Korea Times
amn_close.png
amn_bl.png
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
amn_bl.png
Business
  • Tech
  • Bio
  • Companies
amn_bl.png
Finance
  • Companies
  • Economy
  • Markets
  • Cryptocurrency
amn_bl.png
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to President
  • Letter to the Editor
amn_bl.png
Lifestyle
  • Travel & Food
  • Trends
  • People & Events
  • Books
  • Around Town
  • Fortune Telling
amn_bl.png
Entertainment & Arts
  • K-pop
  • Films
  • Shows & Dramas
  • Music
  • Theater & Others
amn_bl.png
Sports
amn_bl.png
World
  • SCMP
  • Asia
amn_bl.png
Video
  • Korean Storytellers
  • POPKORN
  • Culture
  • People
  • News
amn_bl.png
Photos
  • Photo News
  • Darkroom
amn_NK.png amn_DR.png amn_LK.png amn_LE.png
  • bt_fb_on_2022.svgbt_fb_over_2022.svg
  • bt_twitter_on_2022.svgbt_twitter_over_2022.svg
  • bt_youtube_on_2022.svgbt_youtube_over_2022.svg
  • bt_instagram_on_2022.svgbt_instagram_over_2022.svg
  • Login
  • Register
  • Login
  • Register
  • The Korea Times
  • search
  • all menu
  • Login
  • Subscribe
  • Photos
  • Video
  • World
  • Sports
  • Opinion
  • Entertainment & Art
  • Lifestyle
  • Finance
  • Business
  • National
  • North Korea
  • 1

    INTERVIEWKorean adoptee in Germany reunites with birth family after 42 years

  • 3

    Korea to start mass production of KF-21 in 2024

  • 5

    Yoo Yeon-seok threatens to sue people spreading accusations about him

  • 7

    Sandstorm from China forecast to push up fine dust levels in Korea

  • 9

    Retailers rush to adopt Apple Pay system

  • 11

    Will Apple Pay launch boost local iPhone sales?

  • 13

    INTERVIEW'Welcome to world of art therapy'

  • 15

    INTERVIEWForbes-listed entrepreneur pursues partnerships with Samsung, LG, SK to help Ukraine

  • 17

    Indonesian students advise Korean bank on entering Indonesian market

  • 19

    Long viewed as an outsider, conceptual artist grabs global spotlight in his twilight years

  • 2

    Zebra captured after escaping from Seoul zoo

  • 4

    Will exempting foreign nannies from minimum wage boost Korea's birth rate?

  • 6

    Zoo shares sad story of what caused Sero the zebra to escape

  • 8

    Daughter of North Korean dictator seen wearing $1,900 Dior jacket

  • 10

    Kim Min-gyu, Go Bo-gyeol bid farewell to 'The Heavenly Idol'

  • 12

    INTERVIEWExpert pitches Laotian rural reform to solve NK's chronic food shortages

  • 14

    Kim Nam-gil to embark on Asia fan-meeting tour

  • 16

    Lee Som, Ahn Jae-hong to play married couple in Tving's new series

  • 18

    US Fed lifts key interest rate amid banking sector fears

  • 20

    Samsung, SK chiefs prepare for trips to China amid intensifying 'chip war'

Close scrollclosebutton

Close for 24 hours

Open
  • The Korea Times
  • search
  • all menu
  • Login
  • Subscribe
  • Photos
  • Video
  • World
  • Sports
  • Opinion
  • Entertainment & Art
  • Lifestyle
  • Finance
  • Business
  • National
  • North Korea
Business
Bio
  • Tech
  • Bio
  • Companies
Sat, March 25, 2023 | 04:37
Samsung Biologics highlights essentials for global pharma-CDMO partnerships
Samsung Biologics highlights essentials for global pharma-CDMO partnerships
FRANKFURT - Samsung Biologics, a world-leading contract development and manufacturing organization (CDMO) company that develops and produces drugs for its clients, said demand for biomedicine will exceed supply from 2026, adding that finding the best partner to outsource production is becoming more important for global pharmaceutical companies, according to its executive, Tue...
Baek Byung-yeul | 2022-11-01 19:05
Celltrion seeks new partnerships at CPhI bio exhibition
Celltrion seeks new partnerships at CPhI bio exhibition
FRANKFURT - Celltrion, a Korea-based biopharmaceutical company, is seeking to secure new partnerships at the CPhI bio pharmaceutical exhibition by opening an independent booth, the company said Tuesday. The exhibition is held every year touring major European cities. This year's event is in Frankfurt, Germany, for three days through Thursday, providing opportunities for medic...
Baek Byung-yeul | 2022-11-01 16:35
Samsung Biologics seeks to expand partnerships at CPhI
Samsung Biologics seeks to expand partnerships at CPhI
FRANKFURT - Samsung Biologics and other biotechnology companies in Korea will showcase their technologies and seek more business opportunities with global buyers at this year's CPhI bio pharmaceutical exhibition, according to the companies, Monday. The CPhI is an annual exhibition in the bio pharmaceutical industry held in Europe. This year's event will be held for three days...
Baek Byung-yeul | 2022-10-31 15:36
HLB Science to showcase sepsis treatment at BIO-Europe
HLB Science to showcase sepsis treatment at BIO-Europe
HLB Science, an affiliate of HLB Group, said Friday that it will showcase its sepsis treatment to medical experts and buyers at the BIO-Europe conference, which will be held virtually from Nov. 2 to 4. BIO-Europe is one of the largest pharmaceutical conferences in the biotechnology industry where around 2,000 companies from over 60 countries participate every year to discuss ...
Baek Byung-yeul | 2022-10-28 14:50
SK Bioscience aims to address vaccine inequality through global partnership
SK Bioscience aims to address vaccine inequality through global partnership
SK Bioscience, which developed Korea's first COVID-19 vaccine, SKYCovione, said Thursday that the biotech company aims to address the issue of vaccine inequality by intensifying collaboration with international organizations so that people living in low-income countries will be easily able to prevent life-threatening diseases. Rich, developed countries were the first to get a...
Baek Byung-yeul | 2022-10-20 16:43
HLB completes preparatory meeting with FDA for approval of liver cancer drug
HLB completes preparatory meeting with FDA for approval of liver cancer drug
Local biotech company HLB is stepping up efforts to win a novel drug approval in the United States for its liver cancer treatment Rivoceranib, after completing a pre-new drug application (NDA) meeting with the U.S. Food and Drug Administration (FDA), the company said Wednesday. The company said its U.S. subsidiary Elevar Therapeutics and China's Jiangsu Hengrui Medicine compl...
Baek Byung-yeul | 2022-10-12 17:01
Samsung chief vows to invest $5.2 bil. to create huge lead for bio business
Samsung chief vows to invest $5.2 bil. to create huge lead for bio business
Samsung Electronics Vice Chairman Lee Jae-yong has vowed to invest 7.5 trillion won ($5.2 billion) in the company's biotechnology firm by 2032 to achieve a huge lead with its competitors, Samsung Group said Tuesday. The Samsung chief attended the ceremony for the completion of Samsung Biologics' fourth drug manufacturing plant in Songdo, Incheon. The plant, which went into op...
Baek Byung-yeul | 2022-10-11 16:47
Samsung Biologics launches bispecific antibody platform S-DUAL
Samsung Biologics launches bispecific antibody platform S-DUAL
Samsung Biologics launched S-DUAL, a bispecific antibody platform developed with its own technology with an aim to improve its capability in the contract-based drug development business, the company said Thursday. Bispecific antibodies act on two factors simultaneously, not just one factor, which is more effective than a monospecific antibody that acts on only one factor.
Baek Byung-yeul | 2022-10-06 16:46
Korean biotech firms show off capabilities in Europe
Korean biotech firms show off capabilities in Europe
HLB, Celltrion, NeoImmuneTech and other Korean biotech companies confirmed their competitiveness in Europe as they showcased their new drug development capabilities at the European Society for Medical Oncology (ESMO) Congress, an annual medical oncology fair to share the latest developments in cancer research, they said Tuesday. This year's ESMO Congress was held in Paris for...
Baek Byung-yeul | 2022-09-13 16:46
HLB's liver cancer treatment shows longest overall survival
HLB's liver cancer treatment shows longest overall survival
Local biotech company HLB said its liver cancer treatment candidate Rivoceranib showed over 22 months of overall survival in its Phase 3 clinical trials, the longest in any liver cancer treatment, the company said, Thursday. The company said it plans to hold a meeting with the U.S. Food and Drug Administration (FDA) to apply for approval for new drugs, given the effectiveness...
Baek Byung-yeul | 2022-09-08 14:20
12 3 45678
Top 10 Stories
1Zoo shares sad story of what caused Sero the zebra to escapeZoo shares sad story of what caused Sero the zebra to escape
2Burnout: Cardiothoracic surgery residents work 102 hours a week Burnout: Cardiothoracic surgery residents work 102 hours a week
3More companies adopt electronic voting amid increase in shareholder activism More companies adopt electronic voting amid increase in shareholder activism
4North Korea will pay price for reckless provocations, warns Yoon North Korea will pay price for reckless provocations, warns Yoon
5Second daughter of Daesang chairman promoted to vice president Second daughter of Daesang chairman promoted to vice president
6Churches, Seoul gov't unite to fight low birthrate Churches, Seoul gov't unite to fight low birthrate
7What's next for Do Kwon? What's next for Do Kwon?
8FTC criticized for delaying approval for Hanwha's acquisition of DSME FTC criticized for delaying approval for Hanwha's acquisition of DSME
9Genesis launches 2023 G90 sedan Genesis launches 2023 G90 sedan
10Over 70% of firms unwilling to embrace longer workweek Over 70% of firms unwilling to embrace longer workweek
DARKROOM
  • Turkey-Syria earthquake

    Turkey-Syria earthquake

  • Nepal plane crash

    Nepal plane crash

  • Brazil capital uprising

    Brazil capital uprising

  • Happy New Year 2023

    Happy New Year 2023

  • World Cup 2022 Final - Argentina vs France

    World Cup 2022 Final - Argentina vs France

CEO & Publisher : Oh Young-jin
Digital News Email : webmaster@koreatimes.co.kr
Tel : 02-724-2114
Online newspaper registration No : 서울,아52844
Date of registration : 2020.02.05
Masthead : The Korea Times
Copyright © koreatimes.co.kr. All rights reserved.
  • About Us
  • Introduction
  • History
  • Contact Us
  • Products & Services
  • Subscribe
  • E-paper
  • RSS Service
  • Content Sales
  • Site Map
  • Policy
  • Code of Ethics
  • Ombudsman
  • Privacy Statement
  • Terms of Service
  • Copyright Policy
  • Family Site
  • Hankook Ilbo
  • Dongwha Group